Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The primary objective of this study was to compare the adhesive quality of a new formulation of the Mylan Estradiol Transdermal System with that of Climara® Transdermal System following a single system application in 80 healthy postmenopausal female volunteers. As a secondary objective, primary dermal irritation was assessed after removal of each transdermal system.
Epistemonikos ID: c89ebe0889c2a097b9c72c3512dbccbdabade1ec
First added on: May 04, 2024